perphenazine has been researched along with lithium carbonate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Olfson, M | 1 |
| Young, C | 1 |
| Preskorn, SH; Shad, MU | 1 |
| Ross, J | 1 |
| Buttenfield, J; Frank, E; Haskett, R; Kupfer, DJ; Luckenbaugh, DA; Mallinger, AG; Manji, HK; Thase, ME | 1 |
| Hoti, F; Lähteenvuo, M; Taipale, H; Tanskanen, A; Tiihonen, J; Vattulainen, P; Vieta, E | 1 |
1 review(s) available for perphenazine and lithium carbonate
| Article | Year |
|---|---|
Discontinuation of lithium augmentation in geriatric patients with unipolar depression: a systematic review.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Lithium Carbonate; Perphenazine; Withholding Treatment | 2008 |
1 trial(s) available for perphenazine and lithium carbonate
| Article | Year |
|---|---|
Verapamil augmentation of lithium treatment improves outcome in mania unresponsive to lithium alone: preliminary findings and a discussion of therapeutic mechanisms.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Calcium Channel Blockers; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Perphenazine; Psychiatric Status Rating Scales; Verapamil | 2008 |
5 other study(ies) available for perphenazine and lithium carbonate
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Lithium-responsive schizophrenia and rheumatoid arthritis.
Topics: Adult; Arthritis, Rheumatoid; Drug Therapy, Combination; Female; Humans; Lithium; Lithium Carbonate; Perphenazine; Schizophrenia; Schizophrenic Psychology | 1988 |
A case of neuroleptic malignant syndrome and serotonin disturbance.
Topics: Akathisia, Drug-Induced; Benztropine; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Middle Aged; Neuroleptic Malignant Syndrome; Neurologic Examination; Paroxetine; Perphenazine; Receptors, Serotonin; Trazodone | 1997 |
Pharmacodynamic and pharmacokinetic factors in a case of neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Brain; Drug Interactions; Drug Therapy, Combination; Humans; Lithium Carbonate; Neuroleptic Malignant Syndrome; Paroxetine; Perphenazine; Selective Serotonin Reuptake Inhibitors; Trazodone | 1998 |
Real-world Effectiveness of Pharmacologic Treatments for the Prevention of Rehospitalization in a Finnish Nationwide Cohort of Patients With Bipolar Disorder.
Topics: Administration, Oral; Adult; Bipolar Disorder; Cohort Studies; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Gabapentin; Humans; Injections, Intramuscular; Lithium Carbonate; Male; Middle Aged; Patient Readmission; Perphenazine; Prospective Studies; Psychotropic Drugs; Quetiapine Fumarate; Risk; Risperidone; Treatment Outcome | 2018 |